UiPath shares see a dip — What is pressuring the stock

Traders Union
All News
Financial News
Uipath slides 6.22% today to $11.61

Highlights

UiPath delivered Q4 revenue of $481.1 million, exceeding expectations with 14% growth and achieved full-year GAAP profitability.
Management authorized a $500 million share buyback and unveiled new AI automation solutions for healthcare and compliance verticals.
Despite fundamental outperformance, the stock faces persistent selling and is expected to consolidate between $11.00 and $11.99 amid conflicting technical signals.

Profit, repurchase plan, and AI news as selling persists

UiPath reported fourth-quarter revenue of $481.1 million, surpassing Wall Street estimates with a 14% year-over-year increase, and achieved full fiscal year profitability with GAAP operating income of $57 million. The company authorized a new $500 million stock repurchase and reported annual recurring revenue of $1.853 billion. An AIUC-1 certification was secured for its AI agents and new agentic AI automation solutions were launched for healthcare and financial crime compliance, though price action has remained under broader selling pressure.

Anton Kharitonov, expert at Traders Union, sees UiPath's technical structure as weak and dominated by sellers. He notes that, despite strong revenue and profitability figures, the price remains trapped below key moving averages, which amplifies the downward bias. Kharitonov is wary of overbought momentum indicators and highlights increased volatility as a risk factor. He stresses that the new stock repurchase plan has failed to attract meaningful buying support so far. "Until UiPath reclaims at least the SMA-50 near $13.31, I recommend a defensive approach — the setup favors sellers and further downside risk remains," says Kharitonov.

Viktoras Karapetjanc, expert at Traders Union, believes UiPath's fundamentals remain strong despite short-term price weakness. He highlights the company's robust revenue growth, achieved profitability, and the $500 million buyback as key signals of confidence. Karapetjanc also notes the positive market developments in AI certification and expansion into new sectors. "In my view, the bullish structure remains intact, and I expect the company to attract renewed investor interest as fundamentals come into sharper focus," he asserts.

Parshwa Turakhiya, analyst, sees a mixed sentiment setup with high volatility creating tactical opportunities. He observes oversold signals emerging intraday even as momentum remains negative. Turakhiya notes that sideways consolidation could offer short-term trading setups if $11.00 holds as support. "Traders should watch for whipsaw moves within the $11.00–$11.99 range — patience and nimble execution will be key in this choppy environment," he suggests.

Weak trend conviction as mixed momentum clashes with volatility

On the daily chart, the nearest dynamic support is seen around the Kijun level of $11.41, while significant resistance remains at the SMA-50 near $13.31. Momentum signals show mixed strength: MACD on D1 signals a strong sell, while ADX reads 23.67 and suggests weak trend conviction. Overbought readings on Stoch RSI and CCI indicate stretched conditions, while RSI at 55.25 is mildly positive. BBP also points to an overbought environment, with recent intraday action dominated by sellers. Daily performance saw a notable gap down at the open, followed by a 6.22% decline and a session low near $10.74. The current price is mid-range between session low and high, showing high volatility with ongoing downward pressure. Divergence among momentum and oscillator signals suggests conflicting short-term direction, and intraday selling pressure contrasts with some underlying bullish signals.

Previously it was reported that UiPath is exhibiting short-term strength above its 20-day moving average, though the price remains below both the 50-day and 200-day MAs, reflecting continued medium- and long-term bearish pressure. Technical momentum is mixed, with MACD signaling a strong sell, weak ADX, elevated Stoch RSI, and immediate support at the Ichimoku Kijun while resistance persists near the 50-day and 200-day MAs.

Source of Data: PATH Price Analysis by TU

The analysis is based on a proprietary model combining technical, on-chain, and expert data. Not investment advice. See methodology

This material may contain third-party opinions, none of the data and information on this webpage constitutes investment advice according to our Disclaimer. While we adhere to strict Editorial Integrity, this post may contain references to products from our partners.